News

Together, turmeric and apple cider vinegar could have powerful health benefits. Learn how to incorporate this combo into your ...
The action is intended to build upon the existing program for Medicare drug price negotiations, which was created by the ...
Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...
The FDA has accepted Yuflyma as an interchangeable biosimilar to adalimumab for the treatment of multiple chronic ...
Bausch Health, Canada & pCPA sign LoI for public drug plan coverage of PrCABTREO for treatment of acne vulgaris: Laval, Quebec Saturday, April 12, 2025, 10:00 Hrs [IST] Bausch Hea ...
A well-balanced diet gives your skin the vitamins and nutrients it needs to fight inflammation, recover from injury or ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Common conditions include psoriasis, seborrheic dermatitis, ringworm, and folliculitis. Depending on the cause, you might find relief with over-the-counter medication, medicated shampoos, antibiotics, ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
In this video, Raj Chovatiya, MD, PhD, discusses updates on oral therapies in psoriasis from the American Academy of ...
Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.
Deucravacitinib has been observed as a safe and efficacious treatment for adults with moderate to severe plaque psoriasis for up to 4 years.